CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction

Clinical trial NCT06480968 · COMPLETED

Trial details

NCT number: NCT06480968
Sponsor: Connecta Therapeutics, S.L.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Fragile X Syndrome

Start date: 2023-06-23
Primary completion: 2024-11-11
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.